Do Something.
Surgical Ablation Guidelines are Advancing
Cox Maze IV yields the highest efficacy for Afib treatment, but literature shows progressive efficacy for each additive lesion set of Cox Maze IV
Click here to access this slide as part of the “Why Treat Afib Surgically” slides.
COR: Class of Recommendation
LOE: Level of Evidence
Sources:
January, C. T., et al. (2019). 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation, CIR-0000000000000665.
Badhwar, et al. (2017). The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg, 103(1):329-41.
January, C.T., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 64(21):e1-76.
*Calkins, H., et al. (2017). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm, 14(10):e275-444. AVR/CABG concomitant ablation Class I LOR for symptomatic persistent and long-standing persistent “refractory or intolerant to at least one Class 1 or 3 antiarrhythmic medication.”
Meier, B., et al. (2014). EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace, 16(10):1397-416.
Cox, J.L., et al. (1991). Dr. Cox performed first surgical ablation using maze I; Successful surgical treatment of atrial fibrillation. Review and clinical update. JAMA, 266 (14):1976-80. COR : Class of Recommendation LOE : Level of Evidence